Učitavanje...

SUN-418 An Uncommon Case of Anti-PD1 Agent Induced Secondary Adrenal Insufficiency

Introduction - Nivolumab is a monoclonal anti-programmed cell death receptor 1(PD1) antibody approved for the treatment of unresectable or metastatic melanoma and is known to be associated with a wide spectrum of endocrinologic derangements. The objective of this report is to describe a case of symp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Endocr Soc
Glavni autori: Kumar, Monisha Priyadarshini, Tanphaichitr, Natthavat, Ciltea, Daniela
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2019
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553168/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-418
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!